comparemela.com

Latest Breaking News On - Beyond drug - Page 1 : comparemela.com

Island Pharmaceuticals doses second cohort of subjects in ISLA-101 Single Ascending Dose study

Island Pharmaceuticals Ltd (ASX:ILA) has now dosed all eight subjects in the second cohort of its ISLA-101 Single Ascending Dose (SAD) study. ISLA-101 is a.

New south walesDavid fosterIsland pharmaceuticalsScientia clinical researchContract research organisationSafety review committeeIsland pharmaceuticals ltdDrug developmentAscending doseSingle ascending doseBeyond drug

Island Pharmaceuticals kicks off critical study in Dengue fight

Island Pharmaceuticals Ltd (ASX:ILA), a leader in antiviral drug development, has initiated the first cohort dosing in its single ascending dose (SAD) study.

New south walesDavid fosterIsland pharmaceuticals ltdDrug developmentIsland pharmaceuticalsScientia clinical researchContract research organisationBeyond drug

Island Pharmaceuticals initiates screening for ISLA-101 study to combat mosquito-borne disease

Island Pharmaceuticals Ltd (ASX:ILA) has officially commenced screening subjects for the ISLA-101 single ascending dose study. The company plans to.

New south walesDavid fosterHuman research ethics committee onIsland pharmaceuticals ltdWorld health organizationDrug developmentScientia clinical researchHuman research ethics committeeBeyond drug

vimarsana © 2020. All Rights Reserved.